Balance Sheet Insights: Inozyme Pharma Inc (INZY)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Inozyme Pharma Inc (NASDAQ: INZY) closed at $4.23 up 3.93% from its previous closing price of $4.07. In other words, the price has increased by $3.93 from its previous closing price. On the day, 0.63 million shares were traded. INZY stock price reached its highest trading level at $4.45 during the session, while it also had its lowest trading level at $4.205.

Ratios:

For a deeper understanding of Inozyme Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.68 and its Current Ratio is at 7.68. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.51.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on September 12, 2024, initiated with a Buy rating and assigned the stock a target price of $16.

On May 30, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $14.Wells Fargo initiated its Overweight rating on May 30, 2024, with a $14 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’24 when Treco Douglas A sold 7,523 shares for $6.94 per share. The transaction valued at 52,210 led to the insider holds 20,665 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INZY now has a Market Capitalization of 283827936 and an Enterprise Value of 186920032.

Stock Price History:

Over the past 52 weeks, INZY has reached a high of $7.80, while it has fallen to a 52-week low of $2.71. The 50-Day Moving Average of the stock is -17.91%, while the 200-Day Moving Average is calculated to be -18.64%.

Shares Statistics:

For the past three months, INZY has traded an average of 253.72K shares per day and 277240 over the past ten days. A total of 61.77M shares are outstanding, with a floating share count of 42.62M. Insiders hold about 32.06% of the company’s shares, while institutions hold 63.79% stake in the company. Shares short for INZY as of 1728950400 were 3211598 with a Short Ratio of 12.66, compared to 1726185600 on 3928898. Therefore, it implies a Short% of Shares Outstanding of 3211598 and a Short% of Float of 5.1599998000000005.

Most Popular